{"id":9351,"date":"2018-01-23T09:20:28","date_gmt":"2018-01-23T14:20:28","guid":{"rendered":"https:\/\/medicarereport.org\/?p=9351"},"modified":"2018-01-23T09:20:28","modified_gmt":"2018-01-23T14:20:28","slug":"did-the-government-overpay-for-hundreds-of-drugs-its-complicated","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=9351","title":{"rendered":"Did the government overpay for hundreds of drugs? It\u2019s complicated"},"content":{"rendered":"<p>(By Ike Swetlitz for ST<em>A<\/em>T)<\/p>\n<p class=\"big-cap-wrap danger-zone\"><span class=\"big-cap\">WASHINGTON \u2014 It looked like the watchdog had found something big \u2014 in December 2017, a government\u00a0<a href=\"https:\/\/oig.hhs.gov\/oei\/reports\/oei-03-17-00100.asp\" target=\"_blank\" rel=\"noopener noreferrer\">report<\/a>\u00a0proclaimed that drug companies might have stiffed Medicaid over a billion dollars by pricing some brand-name drugs like generics. <a href=\"https:\/\/www.statnews.com\/2018\/01\/22\/medicaid-drug-payments\/?utm_source=STAT+Newsletters&amp;utm_campaign=b0c2872488-Pharmalot&amp;utm_medium=email&amp;utm_term=0_8cab1d7961-b0c2872488-149624405\">Continue reading article here&#8230;<\/a><\/span><\/p>\n<p class=\"big-cap-wrap danger-zone\"><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Ike Swetlitz for STAT) WASHINGTON \u2014 It looked like the watchdog had found something big \u2014 in December 2017,<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[32,16,15],"tags":[],"class_list":["post-9351","post","type-post","status-publish","format-standard","hentry","category-cms","category-medicaid","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/9351","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=9351"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/9351\/revisions"}],"predecessor-version":[{"id":9352,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/9351\/revisions\/9352"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=9351"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=9351"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=9351"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}